Anson Funds Management LP

10% OwnerMEI Pharma, Inc. (MEIP) · full profile →Form 4 · filed Oct 13, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 11, 2023Option exercise(X)40K$7.00$280K904K
Oct 11, 2023Option exercise(X)10K$7.00$70K914K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 11, 2023Option exercise(X)400$09K
Oct 11, 2023Option exercise(X)100$09K

Transaction Codes

X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-23-002339) within minutes of acceptance. Every field above traces to the original document. Verify it directly: